Therapeutic anti-methamphetamine antibody fragment-nanoparticle conjugates: Synthesis and in vitro characterization

Bioconjugate Chemistry

Volumn 23, Issue 9, 2012, Pages 1864-1872

  Nanaware Kharade, Nisha ^a   Gonzalez, Guillermo A ^a   Lay, Jackson O ^b   Hendrickson, Howard P ^c   Peterson, Eric C ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFFINITY CHROMATOGRAPHY; AMINO ACIDS; ANTIBODIES; BINDING ENERGY; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; SYNTHESIS (CHEMICAL);

ANTIBODY-FRAGMENT; CROSSLINKER; CUSTOMIZABLE; IN-VITRO; NANOPARTICLE CONJUGATE; PHARMACOKINETIC PROPERTIES; POLYAMIDOAMINE DENDRIMERS; SINGLE-CHAIN ANTIBODIES; TERMINAL CYSTEINE; VITRO CHARACTERIZATION;

DENDRIMERS;

ANTIBODY CONJUGATE; CYSTEINE CONJUGATE; DENDRIMER; FUNCTIONAL GROUP; MACROGOL; METHAMPHETAMINE; NANOPARTICLE; POLYAMIDOAMINE; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; THIOL GROUP;

AFFINITY CHROMATOGRAPHY; ARTICLE; BINDING AFFINITY; CONJUGATION; CONTROLLED STUDY; CROSS LINKING; IN VITRO STUDY; METHAMPHETAMINE DEPENDENCE; NANOMEDICINE; NONHUMAN; STOICHIOMETRY; SYNTHESIS;

EID: 84866353023     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc300204n     Document Type: Article

References (30)

1. Segal, D. (1994) Amphetamine and Its Analogs: Psychopharmacology, Toxicology, and Abuse, pp 387-414, Academic Press, San Diego, CA.
2. Laurenzana, E. M., Byrnes-Blake, K. A., Milesi-Hallé, A., Gentry, W. B., Williams, D. K., and Owens, S. M. (2003) Use of anti-(+)-methamphetamine monoclonal antibody to significantly alter (+)-methamphetamine and (+)-amphetamine disposition in rats Drug Metab. Dispos. 31, 1320-1326 (Pubitemid 37310320)
3. Byrnes-Blake, K. A., Laurenzana, E. M., Carroll, F. I., Abraham, P., Gentry, W. B., Landes, R. D., and Owens, S. M. (2003) Pharmacodynamic mechanisms of monoclonal antibody-based antagonism of (+)-methamphetamine in rats Eur. J. Pharmacol. 461, 119-128 (Pubitemid 36174031)
4. McMillan, D. E., Hardwick, W. C., Li, M., Gunnell, M. G., Carroll, F. I., Abraham, P., and Owens, S. M. (2004) Effects of murine-derived anti-methamphetamine monoclonal antibodies on (+)-methamphetamine self-administration in the rat J. Pharmacol. Exp. Ther. 309, 1248-1255 (Pubitemid 38669716)
5. Peterson, E. C. and Owens, S. M. (2009) Designing immunotherapies to thwart drug abuse Mol. Interventions 9, 119-124
6. Roopenian, D. C. and Akilesh, S. (2007) FcRn: the neonatal Fc receptor comes of age Nat. Rev. Immunol. 7, 715-725 (Pubitemid 47327396)
7. Laurenzana, E. M., Hendrickson, H. P., Carpenter, D., Peterson, E. C., Gentry, W. B., West, M., Che, Y., Carroll, F. I., and Owens, S. M. (2009) Functional and biological determinants affecting the duration of action and efficacy of anti-(+)-methamphetamine monoclonal antibodies in rats Vaccine 27, 7011-7020
8. Peterson, E. C., Gunnell, M., Che, Y., Goforth, R. L., Carroll, F. I., Henry, R., Liu, H., and Owens, S. M. (2007) Using hapten design to discover therapeutic monoclonal antibodies for treating methamphetamine abuse J. Pharmacol. Exp. Ther. 322, 30-39 (Pubitemid 46956367)
9. Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., and Langer, R. (2007) Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2, 751-760 (Pubitemid 350223348)
10. Provenzale, J. M. and Silva, G. A. (2009) Uses of nanoparticles for central nervous system imaging and therapy Am. J. Neuroradiol. 30, 1293-1301
11. Zhang, L., Gu, F., Chan, J., and Wang, A. (2008) Nanoparticles in medicine: therapeutic applications and developments Clin. Pharmacol. Ther. 85, 761-769 (Pubitemid 351556021)
12. Svenson, S. and Tomalia, D. A. (2005) Dendrimers in biomedical applications - reflections on the field Adv. Drug Delivery Rev. 57, 2106-2129 (Pubitemid 41759389)
13. Boas, U. and Heegaard, P. M. H. (2004) Dendrimers in drug research Chem. Soc. Rev. 33, 43-63 (Pubitemid 38376610)
14. Sambrook, J. and Russell, D. W. (2001) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
15. Peterson, E. C., Laurenzana, E. M., Atchley, W. T., Hendrickson, H. P., and Owens, S. M. (2008) Development and preclinical testing of a high-affinity single-chain antibody against (+)-methamphetamine J. Pharmacol. Exp. Ther. 325, 124-133 (Pubitemid 351439176)
16. Kurfürst, M. M. (1992) Detection and molecular weight determination of polyethylene glycol-modified hirudin by staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis Anal. Biochem. 200, 244-248
17. Baum, P., Müller, D., Rüger, R., and Kontermann, R. E. (2007) Single-chain Fv immunoliposomes for the targeting of fibroblast activation protein-expressing tumor stromal cells J. Drug Target 15, 399-406 (Pubitemid 47073055)
18. Thomas, J., Sherman, D. B., Amiss, T. J., Andaluz, S. A., and Pitner, J. B. (2007) Synthesis and biosensor performance of a near-IR thiol-reactive fluorophore based on benzothiazolium squaraine Bioconjugate Chem. 18, 1841-1846 (Pubitemid 350219982)
19. Brocchini, S., Godwin, A., Balan, S., Choi, J. W., Zloh, M., and Shaunak, S. (2008) Disulfide bridge based PEGylation of proteins Adv. Drug Delivery Rev. 60, 3-12 (Pubitemid 350181163)
20. Sharma, A., Desai, A., Ali, R., and Tomalia, D. (2005) Polyacrylamide gel electrophoresis separation and detection of polyamidoamine dendrimers possessing various cores and terminal groups J. Chromatogr., A 1081, 238-244 (Pubitemid 40848408)
21. Hermanson, G. (1996) Hermanson: Bioconjugate Techniques, Academic Press, San Diego, CA.
22. Cheng, Y. and Prusoff, W. H. (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction Biochem. Pharmacol. 22, 3099-3108
23. Lee, L. S., Conover, C., Shi, C., aWhitlow, M., and Filpula, D. (1999) Prolonged circulating lives of single-chain Fv proteins conjugated with polyethylene glycol: a comparison of conjugation chemistries and compounds Bioconjugate Chem. 10, 973-981
24. Chapman, A. P. (2002) PEGylated antibodies and antibody fragments for improved therapy: a review Adv. Drug Delivery Rev. 54, 531-545 (Pubitemid 34615547)
25. Luo, D., Haverstick, K., Belcheva, N., Han, E., and Saltzman, W. M. (2002) Poly(ethylene glycol)-conjugated PAMAM dendrimer for biocompatible, high-efficiency DNA delivery Macromolecules 35, 3456-3462 (Pubitemid 34590324)
26. Yang, K., Basu, A., Wang, M., Chintala, R., Hsieh, M. C., Liu, S., Hua, J., Zhang, Z., Zhou, J., Li, M., Phyu, H., Petti, G., Mendez, M., Janjua, H., Peng, P., Longley, C., Borowski, V., Mehlig, M., and Filpula, D. (2003) Tailoring structure-function and pharmacokinetic properties of single-chain Fv proteins by site-specific PEGylation Protein Eng. 16, 761-770 (Pubitemid 37442447)
27. HER-2 single chain Fv fragment 4D5: effects on tumor targeting J. Biol. Chem. 281, 35186-35201 (Pubitemid 46043248)
28. Plesner, B., Westh, P., Hvidt, S., and Nielsen, A. D. (2011) The molar hydrodynamic volume changes of factor VIIa due to GlycoPEGylation J. Pharm. Biomed. Anal. 55, 597-602
29. Celikel, R., Peterson, E. C., Owens, S. M., and Varughese, K. I. (2009) Crystal structures of a therapeutic single chain antibody in complex with two drugs of abuse-methamphetamine and 3,4-methylenedioxymethamphetamine Protein Sci. 18, 2336-2345
30. 125I-labelled polyamidoamine dendrimers in vivo J. Controlled Release 65, 133-148 (Pubitemid 30122922)